Rhythm Pharmaceuticals EV - Enterprise Value 2011-2026 | RYTM

Annual EV - Enterprise Value Rhythm Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
3.48 B	2.6 B	1.34 B	481 M	1.23 B	611 M	785 M	397 M	-1.5 M	5.27 M	-	75.6 M	55.2 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.48 B	-1.5 M	922 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Adagene ADAG	395 M	$ 1.9	-3.11 %	$ 107 M	China
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.31	-4.06 %	$ 7.96 B	Australia
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	725 M	-	-	$ 1.01 B	USA
Amphastar Pharmaceuticals AMPH	2 B	$ 25.87	-0.79 %	$ 1.25 B	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	10.8 M	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Athira Pharma ATHA	-18.3 M	-	-	$ 269 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Ascendis Pharma A/S ASND	726 M	$ 215.29	4.59 %	$ 5 B	Danmark
BioNTech SE BNTX	-6.64 B	$ 105.97	-2.78 %	$ 27.2 B	Germany
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Aytu BioScience AYTU	-15.2 M	$ 2.71	1.88 %	$ 17 M	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Arrowhead Pharmaceuticals ARWR	6.02 B	$ 64.74	1.41 %	$ 8.66 B	USA
Brickell Biotech BBI	515 K	-	-5.38 %	$ 6.06 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 3.96	-1.0 %	$ 8.62 B	Israel
BeiGene, Ltd. BGNE	253 B	-	0.49 %	$ 251 B	Cayman-islands
Burford Capital Limited BUR	3.22 B	$ 9.63	-0.93 %	$ 1.56 B	Britain
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Adaptimmune Therapeutics plc ADAP	2.15 B	-	-15.15 %	$ 60.3 M	Britain
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Bellicum Pharmaceuticals BLCM	-9.74 M	-	-9.72 %	$ 5.89 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
AlloVir ALVR	-64.1 M	-	4.14 %	$ 49.1 M	USA
BioLineRx Ltd. BLRX	15 M	$ 2.97	3.12 %	$ 908 M	Israel
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
Biogen BIIB	28.3 B	$ 164.87	0.27 %	$ 24 B	USA
Bio-Path Holdings BPTH	4.67 M	-	-	$ 100 K	USA
BioVie BIVI	-12.6 M	$ 1.23	2.07 %	$ 1.82 M	USA
Baudax Bio BXRX	29.8 M	-	0.59 %	$ 63 K	USA
Calithera Biosciences CALA	916 M	-	-10.95 %	$ 876 K	USA
Arena Pharmaceuticals ARNA	5.65 B	-	-6.81 %	$ 3.04 B	USA
Athersys ATHX	-37.4 M	-	3.77 %	$ 22.4 M	USA
Cara Therapeutics CARA	71.1 M	-	-3.03 %	$ 260 M	USA
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA